News & Comment

Creators of software widely used in computational biology discuss the factors that contributed to their success

Disputes over how to assess a foodstuff's safety continue to play into public fears about transgenic crops.

Next-generation sequencing has provided long-sought-after noninvasive tests for prenatal screening, and a small cadre of companies has stepped up to push it into the clinic at warp speed.

A panel of experts discusses the challenge of translating findings from current mouse models to the clinic.

Academic tech transfer keeps on spinning out startups, but the pool of capital to sustain such ventures is dwindling.

Nine experts discuss the challenges in translating current research on the human microbiome into strategies for disease prediction, diagnosis and therapy.

Five years after the launch of the Human Microbiome Project, several ventures are seeking to capitalize on the clinical promise of microbiome modulation. Commercialization of drugs that influence the human flora poses some unique scientific, translational and regulatory challenges.